Research Grade Felvizumab
Felvizumab[HuRSV19VHFNS/VK, RSHZ19, RSVmonoclonalantibody, SB209763]isahumanisedmonoclonalantibody (IgG1) preparedbythehumanizationofanFprotein-specificmurineMAb.Ininvitrostudies, palivizumab, anotherhumanizedMabspecificfortheFproteinofRSV, was4to5-foldmorepotentthanfelvizumabinneutralisingRSV (Scott, 1999) .RSHZ19 (Felvizumab) RSVThisantibodywas
Product Specifications
Product Name Alternative
SB209763, HuRSV19VHFNS/VK, RSHZ19monoclonalantibody, SB209763, CAS:167747-20-8
Expression System
Mammalian Cells
Host
Humanized
Target
F, FusionglycoproteinF0, FusionglycoproteinF2, p27, Interveningsegment, Pep27, Peptide27, FusionglycoproteinF1
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
1 mg/mL
Purity
> 95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Notes
For research use only. Not suitable for clinical or therapeutic use.
Species
HRSV-A
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
